Lv65
2030 积分 2024-11-20 加入
A phase II study of antibody-drug conjugate, TAK-264 (MLN0264) in previously treated patients with advanced or metastatic pancreatic adenocarcinoma expressing guanylyl cyclase C
3天前
已完结
Phase II study of the antibody-drug conjugate TAK-264 (MLN0264) in patients with metastatic or recurrent adenocarcinoma of the stomach or gastroesophageal junction expressing guanylyl cyclase C
3天前
已完结
Evidence that cell surface localization of serine protease activity facilitates cleavage of the protease activated receptor CDCP1
1个月前
已完结
EGF inhibits constitutive internalization and palmitoylation-dependent degradation of membrane-spanning procancer CDCP1 promoting its availability on the cell surface
1个月前
已完结
CAF-derived LRRC15 orchestrates macrophage polarization and limits PD-1 immunotherapy efficacy in glioblastoma
2个月前
已完结
Expression and clinical implications of leucine‐rich repeat containing 15 (LRRC15) in osteosarcoma
2个月前
已完结
LRRC15+ myofibroblasts dictate the stromal setpoint to suppress tumour immunity
2个月前
已完结
Resistance to PD-1/PD-L1 immune checkpoint blockade in advanced non-small cell lung cancer
2个月前
已完结
Identification of an Integrin α6‐Targeted Peptide for Nasopharyngeal Carcinoma‐Specific Nanotherapeutics
2个月前
已完结
CDCP1: A promising diagnostic biomarker and therapeutic target for human cancer
2个月前
已完结
皖公网安备34019202002308
